
Stanford’s 37,000-Agent Virtual Biotech
Stanford researchers have expanded a small multi-agent virtual lab into a Virtual Biotech with tens of thousands of specialized AI agents. The system has designed nanobody proteins that outperformed earlier human designs, while one drug design was independently confirmed by Merck.
VentureBeat · 49d ago





















